BioCatalystWatch
SYREWorkspace / SYRE / OverviewCompany library
Spyre Therapeutics, Inc. logo

Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc. (SYRE)

Website

Price
Market cap
Next catalystExpected Q3 2027SPY120 — SPY001 + SPY002; SKYLINE and long-term extension · Phase 2 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

SPY003

IL-23p19

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

SPY001

α4β7 integrin

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

SPY002

TL1A

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

SPY001

α4β7 integrin

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

SPY002

TL1A

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

SPY003

IL-23p19

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

SPY003

IL-23p19

PreINDP1P2P3FilingApproved
SPY002

TL1A

PreINDP1P2P3FilingApproved
SPY007

IL-17A × IL-17F

SPY072

TL1A

PreINDP1P2P3FilingApproved
SPY072

TL1A + IL-17A/F

PreINDP1P2P3FilingApproved
Upcoming / outlook

TL1A × IL-17A × IL-17F

pegtarviliase

PreINDP1P2P3FilingApproved

Partner / License out

History / paused

SPY072

TL1A

PreINDP1P2P3FilingApproved
SPY072

TL1A

PreINDP1P2P3FilingApproved
SPY072

TL1A

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

SYRE PR & News

PR & News

SYRE SEC archive